Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR5 | Q9H1C0 | 4/20 | 0.59 |
| ▸ | LPAR3 | Q9UBY5 | 10/20 | 0.58 |
| ▸ | LPAR1 | Q92633 | 9/20 | 0.58 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.52 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.51 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.47 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.46 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28698390 | 1.00 | LPAR5 (0.59) | LPAR5LPAR3LPAR1LPAR2SMPD1 | |
| SCHEMBL28992600 | 1.00 | LPAR5 (0.59) | LPAR5LPAR3LPAR1LPAR2SMPD1 | |
| SCHEMBL21291920 | 1.00 | LPAR5 (0.59) | LPAR5LPAR3LPAR1LPAR2SMPD1 | |
| SCHEMBL28992598 | 1.00 | LPAR5 (0.59) | LPAR5LPAR3LPAR1LPAR2SMPD1 | |
| SCHEMBL29014861 | 1.00 | LPAR5 (0.59) | LPAR5LPAR3LPAR1LPAR2SMPD1 | |
| SCHEMBL7176541 | 0.98 | LPAR5 (0.57) | LPAR5LPAR3LPAR1LPAR2SMPD1 | |
| SCHEMBL21291931 | 0.93 | LPAR5 (0.50) | LPAR5LPAR3LPAR1LPAR2SMPD1 | |
| SCHEMBL21291942 | 0.90 | LPAR5 (0.55) | LPAR5LPAR3LPAR1LPAR2SMPD1 | |
| SCHEMBL8096447 | 0.87 | LPAR3 (0.48) | LPAR5LPAR3LPAR1LPAR2SMPD1 | |
| SCHEMBL10566910 | 0.86 | LPAR3 (0.66) | LPAR5LPAR3LPAR1LPAR2SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6656499-B1 | Lipid bilayer comprising phospholipid and fatty acylated amino acid entrapping surfactant stabilized oil in water emulsion | PHARMADERM LABORATORIES, LTD. (CA) | 2003-12-02 | — | — | US | disclosed |
| US-20030119774-A1 | Compositions and methods for stimulating an immune response | PHARMADERM LABORATORIES, LTD. (CA) | 2003-06-26 | — | — | US | disclosed |
| WO-2003026688-A1 | BIPHASIC LIPOSOMES CONTAINING IMMUNOGEN AND CPG, FOR STIMULATING AN IMMUNE RESPONSE | PHARMADERM LABORATORIES, LTD. (CA) | 2003-04-03 | — | — | WO | disclosed |
| EP-1265638-A1 | COMPOSITIONS FOR TRANSDERMAL AND TRANSMUCOSAL ADMINISTRATION OF THERAPEUTIC AGENTS | Pharmaderm Laboratories Ltd. (CA) | 2002-12-18 | — | — | EP | disclosed |
| WO-2001035998-A1 | COMPOSITIONS FOR TRANSDERMAL AND TRANSMUCOSAL ADMINISTRATION OF THERAPEUTIC AGENTS | PHARMADERM LABORATORIES, LTD. (CA) | 2001-05-25 | — | — | WO | disclosed |
| EP-1023054-A1 | BIPHASIC LIPID VESICLE COMPOSITION FOR TRANSDERMAL ADMINISTRATION OF AN IMMUNOGEN | Pharmaderm Laboratories Ltd. (CA) | 2000-08-02 | — | — | EP | disclosed |
| US-5993852-A | THE IMMUNOGEN IS ENTRAPPED IN LIPID VESICLES HAVING A OIL-IN-WATER EMULSION IN THE CENTRAL CORE COMPARTMENT. | PHARMADERM LABORATORIES LTD. (CA) | 1999-11-30 | — | — | US | disclosed |
| WO-1999011247-A1 | BIPHASIC LIPID VESICLE COMPOSITION FOR TRANSDERMAL ADMINISTRATION OF AN IMMUNOGEN | PHARMADERM LABORATORIES, LTD. (CA) | 1999-03-11 | — | — | WO | disclosed |